Charles Evan Ballantyne

Insider Reports History

Location
Hopkinton, MA
Signature
/s/ Cathy Rude, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Evan Ballantyne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 100,000 $586,000 $5.86 10 Apr 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 50,000 $125,000 $2.5 10 Apr 2023 Direct

Insider Reports Filed by Charles Evan Ballantyne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GANX Gain Therapeutics, Inc. 10 Apr 2023 2 $0 4 Chief Financial Officer 12 Apr 2023, 17:36
GANX Gain Therapeutics, Inc. 10 Apr 2023 0 $0 3 Chief Financial Officer 12 Apr 2023, 17:35